Home
LillyPad

LillyPad Market Share Analysis for August 2026

Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries.

Health > Health - Other

Domainlillyindia.co.in

Year Founded1876

Employees> 10001

Annual Revenue> $1B

LillyPad

LillyPad (including company regionals)

lillyindia.co.in

See more website traffic and engagement information

LillyPad Revenue up to August 2026 is > 1B

revenue generated by LillyPad top domains

LillyPad top domains revenue over 3 years

Revenue for LillyPad top domains

lillyindia.co.in> 1B

See more with Sales Intelligence

LillyPad Stock price in August 2026

LillyPad stock is traded under the ticker #LLY. Below you can review LillyPad stock performance in the past 12 months up to August 2026

Total visits to LillyPad's top domains

Understand LillyPad market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in LillyPad's top domains

Analyze LillyPad engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on LillyPad's top domains

See how LillyPad keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

LillyPad top competitors by domain

Top similar sites in August 2026, ranked by their affinity

lilly.com.mxCompany NameLillyPadEmployees> 10001HQUnited States, Massachusetts, CambridgeAnnual revenue> $1BTotal visits--Health > Health - Other

Top technologies used by LillyPad

These are the website technologies, by industry, used by LillyPad top domains

Mobile (3)

Meta Viewport

Advertising (2)

DoubleClick

Recruitment (2)

IBM Kenexa

Social (2)

Instagram

More Technologies

3

See all

News & Signals from LillyPad

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsLillyindia decreased headcount by 120 on Oct 1st '23.In October, US drugmaker Eli Lilly sold the marketing rights of its anti-diabetes drugs to Cipla and laid off 120 employees in India.

NewsLillyindia launched Copellor in India on Mar 14th '23.New Delhi: The leading biopharma major, Eli Lilly has launched Copellor®(Ixekizumab) in India for the treatment of adults with moderate-to-severe plaque psoriasis.

NewsLillyindia launches drug to treat moderate-to-severe plaque psoriasis in India.Eli Lilly has launched a new drug to treat moderate-to-severe plaque psoriasis in India.